Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Liber Derma ApS
APS
Bankrupt
CVR 43791567
Øverødvej 36B
General medical practice activities · NACE 8621
Est. 2023
— employees
www.liberderma.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK 657K
EBITDA margin
100.0%
Equity ratio
3.5%
Financial strength
Net profit 2023
DKK 657K
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2023
Key figures
Annual report 2023
Revenue
DKK 657K
—
EBITDA
DKK 657K
—
Net profit
DKK 657K
—
Total assets
DKK 1,1M
—
Equity
DKK 40K
—
Employees
—
—
Company information
Legal name
Liber Derma ApS
CVR number
43791567
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
20. januar 2023
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at at drive lægeklinik, samt enhver virksomhed i hermed stående forbindelse.
Contact
Address
Øverødvej 36B
Phone
+4531116633
Email
Thorup@liberderma.dk
Website
www.liberderma.dk
Recent events
1 entries
Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2023
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2023
Income statement
DKK thousands
Item
2023
Revenue
657
Staff expenses
-0
EBITDA
657
Depreciation & amort.
-0
EBIT
657
Net financials
0
Profit before tax
657
Tax
-0
Net profit
657
Balance sheet
DKK thousands
Item
2023
Total assets
1.130
Equity
40
Long-term debt
0
Short-term debt
1.090
Total debt
1.090
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2023
2023
Equity ratio
3.5%
This company
38.2%
Market median
-91% vs market
2023
2023
Return on equity
1642.5%
This company
18.4%
Market median
+8827% vs market
2023
2023
Net profit margin
100.0%
This company
8.1%
Market median
+1135% vs market
2023
2023
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
2023
2023
Debt / equity
27.24×
This company
0.62×
Market median
-4294% vs market
2023
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-20 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SF
Søren Francois Fantini
Chief Executive Officer
Chief Executive Officer
2025
—
—
PZ
Pardis Zarifkar
Management
Management
2023
—
—
AT
Anders Thorup Nielsen
Chief Executive Officer
Chief Executive Officer
2023
—
—
OL
Ole Larsen
Unofficial title
Unofficial title
2025
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Zarifkar ApS
Company
50.0%
50.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Zarifkar ApS
Liber Derma ApS
(this company)
Board network connections
Board members of Liber Derma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Søren Francois Fantini
Chief Executive Officer
0 companies
Pardis Zarifkar
Management
0 companies
Anders Thorup Nielsen
Chief Executive Officer
0 companies
Ole Larsen
Unofficial title
0 companies